dentalcorp Holdings Past Earnings Performance
Past criteria checks 0/6
dentalcorp Holdings has been growing earnings at an average annual rate of 22.5%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 15.4% per year.
Key information
22.5%
Earnings growth rate
42.3%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 15.4% |
| Return on equity | -4.0% |
| Net Margin | -4.7% |
| Next Earnings Update | 12 Nov 2024 |
Recent past performance updates
Recent updates
dentalcorp Holdings Ltd.'s (TSE:DNTL) Shareholders Might Be Looking For Exit
Oct 16
Here's Why dentalcorp Holdings (TSE:DNTL) Has A Meaningful Debt Burden
Aug 03dentalcorp Holdings Ltd.'s (TSE:DNTL) Business Is Yet to Catch Up With Its Share Price
Jun 03The dentalcorp Holdings Ltd. (TSE:DNTL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 13Here's Why dentalcorp Holdings (TSE:DNTL) Has A Meaningful Debt Burden
Apr 13Returns On Capital Are Showing Encouraging Signs At dentalcorp Holdings (TSE:DNTL)
Feb 16dentalcorp Holdings Ltd.'s (TSE:DNTL) 27% Price Boost Is Out Of Tune With Revenues
Dec 22Investors Will Want dentalcorp Holdings' (TSE:DNTL) Growth In ROCE To Persist
Nov 06Analyst Estimates: Here's What Brokers Think Of dentalcorp Holdings Ltd. (TSE:DNTL) After Its First-Quarter Report
May 15An Intrinsic Calculation For dentalcorp Holdings Ltd. (TSE:DNTL) Suggests It's 39% Undervalued
Feb 11Investors Will Want dentalcorp Holdings' (TSE:DNTL) Growth In ROCE To Persist
Nov 22An Intrinsic Calculation For dentalcorp Holdings Ltd. (TSE:DNTL) Suggests It's 46% Undervalued
Aug 28Revenue & Expenses Breakdown
How dentalcorp Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,471 | -68 | 473 | 0 |
| 31 Mar 24 | 1,440 | -64 | 470 | 0 |
| 31 Dec 23 | 1,426 | -86 | 469 | 0 |
| 30 Sep 23 | 1,395 | -44 | 466 | 0 |
| 30 Jun 23 | 1,370 | -49 | 450 | 0 |
| 31 Mar 23 | 1,328 | -39 | 425 | 0 |
| 31 Dec 22 | 1,250 | -17 | 401 | 0 |
| 30 Sep 22 | 1,192 | -66 | 388 | 0 |
| 30 Jun 22 | 1,130 | -70 | 379 | 0 |
| 31 Mar 22 | 1,064 | -162 | 423 | 0 |
| 31 Dec 21 | 1,031 | -160 | 411 | 0 |
| 30 Sep 21 | 984 | -149 | 397 | 0 |
| 30 Jun 21 | 939 | -156 | 401 | 0 |
| 31 Mar 21 | 731 | -114 | 283 | 0 |
| 31 Dec 20 | 666 | -157 | 262 | 0 |
| 31 Dec 19 | 767 | -64 | 234 | 0 |
| 31 Dec 18 | 601 | -117 | 203 | 0 |
Quality Earnings: DNTL is currently unprofitable.
Growing Profit Margin: DNTL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DNTL is unprofitable, but has reduced losses over the past 5 years at a rate of 22.5% per year.
Accelerating Growth: Unable to compare DNTL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DNTL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Return on Equity
High ROE: DNTL has a negative Return on Equity (-3.97%), as it is currently unprofitable.